ML278
ML278 is an efficient, low toxicity, and plasma stable SR-BI (IC50 = 6 nM) lipid uptake inhibitor. ML278 enhances HDL binding while inhibiting SR-BI mediated lipid uptake. ML278 can be used for research on metabolic conditions[1].
Product Specifications
CAS Number
1604821-43-3
UNSPSC
12352005
Target
Scavenger Receptor Class B type I (SR-BI)
Related Pathways
Immunology/Inflammation
Field of Research
Metabolic Disease
Smiles
O=C(NC1=NC(C2=CC3=C(N(C(COC)=O)CC3)C=C2)=CS1)C4=CC(OC)=CC(OC)=C4
Molecular Formula
C23H23N3O5S
Molecular Weight
453.51
References & Citations
[1]Dockendorff C, et al. Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI) -Mediated Lipid Transport. ACS Med Chem Lett. 2015 Feb 2;6 (4) :375-380.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1197457-01 0.02 mg (E-Coli)
Recombinant Shigella boydii serotype 18 LPS-assembly lipoprotein lptE (lptE)
Sign In for Pricing
View Details MBS1197457-02 0.1 mg (E-Coli)
Recombinant Shigella boydii serotype 18 LPS-assembly lipoprotein lptE (lptE)
Sign In for Pricing
View Details MBS1197457-03 0.02 mg (Yeast)
Recombinant Shigella boydii serotype 18 LPS-assembly lipoprotein lptE (lptE)
Sign In for Pricing
View Details MBS1197457-04 0.1 mg (Yeast)
Recombinant Shigella boydii serotype 18 LPS-assembly lipoprotein lptE (lptE)
Sign In for Pricing
View Details MBS1197457-05 0.02 mg (Baculovirus)
Recombinant Shigella boydii serotype 18 LPS-assembly lipoprotein lptE (lptE)
Sign In for Pricing
View Details